[PDF] Top 20 Recommendations for the design of small population clinical trials

... in small clinical ...Consequently, trials set up in these low prevalence conditions face many challenges, including heterogeneity in the patient population, difficulty in clinical trial ... See full document

... in small-population group trials by strictly following the concept of an improved integration of design, conduct and analysis of clinical trials from various ...on small- ... See full document

... al. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical ... See full document

... in trials, the Clinical Trials Transformation Initiative (CTTI) is presenting the first comprehensive, evidence-based set of recommendations for incorporating the perspectives of patients and ... See full document

... for clinical trials in small populations in four ...for small population clinical trials using a Bayesian decision-theoretic framework to compare costs with potential ... See full document

... a clinical trial as ‘a controlled study involving human subjects, designed to evaluate prospectively the safety and efficacy of new drugs or devices or of behavioral interventions’ ...their clinical ... See full document

... the population, the bias gets markedly increased (often more than doubled) when only significant results are reported highlighting the effect of reporting bias which may be even more problematic than the bias ... See full document

... However, it could also reduce generalizability if a small number of patients make up the bulk of observations. For example, consider a trial where 20 patients contrib- ute 200 observations; these patients may be ... See full document

... study design: non-clinical studies; (ii) study population: non-adult population, women with pregnancy or lactation, patients received liver transplantation, patients co-infected with hepatitis ... See full document

... adaptive design methods in clinical trials, it is suggested that the feasibility of certain adaptations such as changes in study endpoints/hypotheses be care- fully evaluated to prevent from any ... See full document

... The accuracy and precision of the treatment effect estimators in subgroup analysis is also crucial to the development of novel treatments and decisions about treatment implementation. Especially, bias is ubiquitous in ... See full document

... and clinical het- erogeneity was observed for some endpoints, although this was significant for the key endpoints of infectious complications and ...definitive clinical trials are ur- gently needed ... See full document

... In this chapter we extend the analytical framework of LDT and propose re- weighted versions of the usual score estimating equation and the score test in the Cox model to be used for the analysis of TSRD clinical ... See full document

... neously reported during placebo administration in 109 double-blind placebo-controlled phase 1 pharmacological studies involving 1228 healthy volunteers. All the stud- ies included single versus repeated administration of ... See full document

... priate design is not ...appropriate design(s) for given disease-drug-outcome ...published clinical trials, to ascer- tain if alternative study designs could have been ... See full document

... the clinical trial. The need for an adequate control population and the requirement of progressive disease at the time of enrollment in a trial with TTP as the primary endpoint may affect the rate of ... See full document

... global population affected by a rare disease at some stage in their life [6], resulting in consider- able total health care cost ...be small compared to the objective of the international rare disease ... See full document

... regulate clinical trials in ...of clinical research, and facilitate transnational clinical tri- ...conducting clinical trials have remained at national and international ...for ... See full document

... In trials in general, this balance is achieved by defining in the trial protocol arrangements for interim analysis to establish whether or not equipoise still exists and, if it does not and one treatment has been ... See full document

... the clinical specimens that are used to diagnose lung cancers (ie, sputum, pleural effusion, bron- chial washing, and surgically resected tissue) contain numer- ous normal ... See full document